Summary
Antagonists of the putative peptide neurotransmitter substance P have been found to produce pronounced cardiovascular effects when administered into the spinal subarachnoid space. These previous studies have not, however, provided any direct evidence that these effects result from interaction with substance P receptors. The present study was designed to characterize the modification of cardiovascular function resulting from administration of these compounds, and evaluate their effects on the integrity of spinal cord function. Intrathecal administration of two substance P antagonists produced a depressor response accompanied by a reduction of hindquarter vascular resistance. Following administration of a substance P antagonist, the integrated cardiovascular responses to electrical stimulation of the renal afferent nerves and ventrolateral medulla were markedly attenuated. Intrathecal administration to conscious rats of three substance P antagonists led to a variety of sensory and motor dysfunctions, including loss of spontaneous motor function, responsiveness to mechanical and thermal stimuli, and bladder function. No such effects were produced by administration of substance P, luteinizing hormone releasing hormone (LHRH), or LHRH antagonist. These effects from administration of a substance P antagonist were associated with a dose-dependent necrosis of spinal cord tissue. The necrosis may be secondary to ischemia since pretreatment with the vasodilator adenosine significantly delayed or blocked the sensory and motor dysfunctions. This conclusion was supported by the demonstration that cerebrovascular smooth muscle (pial vessels) was constricted by a SP antagonist. Taken together, these data suggest that substance P antagonists appear to non-specifically block transmission in the spinal cord, by mechanisms which may involve reduction of blood flow to the spinal cord.
Similar content being viewed by others
References
Aars H, Akre S (1970) Reflex changes in sympathetic activity and arterial blood pressure evoked by afferent stimulation of the renal nerve. Acta Physiol Scand 78: 189–188
Akerman B, Rosell S, Folkers K (1982) Intrathecal (D-Pro2,D-Trp7,9)-SP elicits hypoalgesia and motor blockade in the rat and antagonizes noxious responses induced by substance P. Acta Physiol Scand 114: 631–633
Björkroth U, Rosell S, Xu J, Folkers K (1982) Pharmacological characterization of four related substance P antagonists. Acta Physiol Scand 116: 167–173
Brown JR, Hunter JC, Jordan CC, Tyers MB, Ward P, Whittington AR (1986) Problems with peptides — all that glisters is not gold. Trends Neurosci 9: 100–102
Ciriello J, Calaresu FR (1983) Central projections of afferent renal fibers in the rat: an anterograde transport study of horseradish peroxidase. J Auton Nerv Syst 8: 273–285
Cox BF, Webb RL, Brody MJ (1984) Cardiovascular effects of intrathecal administration of a substance P antagonist. Fed Proc 43: 310
D'Amour FE, Smith DL (1941) A method for determining loss of pain sensation, J Pharmacol Exp Ther 72: 74–79
Donovan MK, Wyss JM, Winternitz SR (1983) Localization of renal sensory neurons using fluorescent dye technique. Brain Res 259: 119–122
Freedman J, Hökfelt T, Jansson G, Post C (1986) Thyrotropin-releasing hormone (TRH) counteracts neuronal damage induced by a substance P antagonist. Exp Brain Res 62: 175–178
Haywood JR, Shaffer RA, Fastenow C, Fink GD, Brody MJ (1981) Regional blood flow measurement in the conscious rat with a pulsed Doppler flowmeter. Am J Physiol 241: H273–278
Helke CJ, Neil JJ, Massari VJ, Loewy AD (1982) Substance P neurons project from the ventral medulla to the intermediolateral cell column and ventral horn in the rat. Brain Res 243: 147–152
Helke CJ, Phillips ET, O'Neill JT (1986) Intrathecal administration of a substance P (SP) receptor antagonist: cardiovascular assessment of non-specific effects. Soc Neurosci Abstr 12: 1157
Hökfelt T, Vincent S, Hellsten L, Rosell S, Folkers K, Markey K, Goldstein M, Cuello C (1981) Immunohistochemical evidence for a “neurotoxic” action of D-Pro2,D-Trp7,9)-substance P, an analogue with substance P antagonistic activity. Acta Physiol Scand 113: 571–573
Keeler J, Helke C (1985) Spinal cord substance P mediates bicuculline-induced activation of cardiovascular responses from the ventral medulla. J Auton Nerv Syst 13: 19–33
Keeler JR, Charlton CG, Helke CJ (1985) Cardiovascular effects of spinal cord substance P: studies with a stable receptor agonist. J Pharmacol Exp Ther 233: 755–760
Kuo DC, Oravitz J, Eskay R, DeGroat WC (1984) Substance P in renal afferent perikarya identified by retrograde transport of fluorescent dye. Brain Res 323: 168–171
Lembeck F, Donnerer J (1983) Reflex fall in blood pressure mediated by capsaicin-sensitive afferent fibers of the rat splanchnic nerve. Naunyn Schmiedeberg's Arch Pharmacol 322: 286–289
Lindenberg R (1982) Tissue reactions in the gray matter of the central nervous system. In: Haymaker W, Adams RD (eds) Histology and histopathology of the nervous system. Charles C Thomas Publisher, Springfield, pp 980–1118
Ljungdahl A, Hökfelt T, Nilsson G (1978) Distribution of substance P — like immunoreactivity in the central nervous system of the rat. I. Cell bodies and nerve terminals. Neuroscience 3: 861–943
Loewy AD, Sawyer WB (1982) Substance P antagonist inhibits vasomotor responses elicited from ventral medulla in rat. Brain Res 245: 379–383
Matsumura H, Sakurada T, Hara A, Kuwahara H, Ando R, Sakurada S, Kisara K (1985) Intrathecal substance P analogue causes motor dysfunction in the rat. Neuropharmacology 24: 811–813
Mayhan WG, Heistad DD (1985) Permeability of blood-brain barrier to various-sized molecules. Am J Physiol 298: H712-H718
Piercey MF, Schroeder LA, Folkers K, Xu JC, Horig J (1981) Sensory and motor functions of spinal cord substance P. Science 214: 1361–1363
Post C, Paulsson I (1985) Antinociceptive and neurotoxic actions of substance P analogues in the rat's spinal cord after intrathecal administration. Neurosci Lett 57: 159–169
Rodriguez R, Salt T, Cahusac M, Hill R (1983) The behavioral effects of intrathecally administered (D-Pro2 D-Trp7,9)-substance P, an analogue with presumed antagonist actions in the rat. Neuropharmacology 22: 173–176
Rosell S, Björkroth U, Xu J, Folkers K (1983) The pharmacological profile of a substance P (SP) antagonist. Evidence for the existence of subpopulations of SP receptors. Acta Physiol Scand 117: 445–449
Schrauwen E, Houvenaghel A (1980) Substance P: a powerful intestinal vasodilator in the pig. Pflügers Arch 386: 281–284
Takano Y, Martin JE, Leeman SE, Loewy AD (1984) Substance P immunoreactivity released from rat spinal cord after kainic acid excitation of the ventral medulla oblongata: a correlation with increases in blood pressure. Brain Res 291: 168–172
Takano Y, Sawyer WB, Loewy AD (1985) Substance P mechanisms of the spinal cord related to vasomotor tone in the spontaneously hypertensive rat. Brain Res 334: 105–116
Takano Y, Sawyer WB, Sanders NL, Loewy AD (1985) LH-RH analogue acts as substance P antagonist by inhibiting spinal cord vasomotor responses. Brain Res 337: 357–361
Ueda H, Uchida Y, Kamiska K (1967) Mechanism of the reflex depressor effect by kidney in dog. Jpn Heart J 8: 597–606
Von Euler U, Gaddum J (1931) An unidentified depressor substance in certain tissue extracts. J Physiol (Lond) 72: 74–87
Yaksh TL, Rudy TA (1976) Chronic catheterization of the spinal subarachnoid space. Physiol Behav 17: 1031–1036
Author information
Authors and Affiliations
Additional information
Supported by grants HL-14388, GM07069, and a gift from the Searle Family Trust Fund
Rights and permissions
About this article
Cite this article
Cox, B.F., Schelper, R.L., Faraci, F.M. et al. Autonomic, sensory, and motor dysfunction following intrathecal administration of three substance P antagonists*. Exp Brain Res 70, 61–72 (1988). https://doi.org/10.1007/BF00271848
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00271848